DarioHealth
DarioHealth is a New York-based medical device company that designs and develops blood glucose management and monitoring systems for diabetes patients.
Business Model:
Revenue: $26.9M
Employees: 51-200
Industries / Tags:
Detailed DarioHealth Information
Geographic Data
Address: 142 W. 57th Street
City: New York
State: NY
Zip: 10019
Country: US
Financial Info
Stage:
post ipo debt
Raised Last:
$50M
Raised Total:$199M
Social
Metrics
755,637Website Global Rank
51,790Website Monthly Traffic
Twitter Followers
Description
DarioHealth is a New York-based medical device company that designs and develops blood glucose management and monitoring systems for diabetes patients.
Contact Phone:
+18008955921
Contact Email:
DarioHealth went public on 4/9/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/9/2013
IPO Valuation:
$46M
Ticker Symbol:
DRIO
IPO Price:
$2.3/share
Amount Raised:
$21M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2013 | Venture Round | 1 | $10M |
SternAegis SternAegis |
10/2012 | Venture Round | $1.2M | 5/2013 | Post-IPO Equity | $10M | 10/2011 | Seed Round | $805k | 1/2021 | Post-IPO Equity | 6 | $70M |
Farallon Capital Management Driehaus Capital Management Nantahala Capital Management Perceptive Advisors Phoenix Insurance Company Pura Vida Investments Farallon Capital Management Driehaus Capital Management Nantahala Capital Management Perceptive Advisors Phoenix Insurance Company Pura Vida Investments |
8/2015 | Post-IPO Equity | $789.5k | 6/2015 | Post-IPO Equity | $461.7k | 2/2015 | Post-IPO Equity | $1.6M | 2/2014 | Post-IPO Equity | $4.2M | 9/2014 | Post-IPO Equity | $4.2M | 10/2019 | Post-IPO Equity | 1 | $21.3M |
SternAegis SternAegis |
7/2020 | Post-IPO Equity | 5 | $28.6M |
SternAegis Soleus Capital Psagot Investment House Phoenix Insurance Company Nantahala Capital Management SternAegis |
1/2011 | Pre Seed Round | 1 | - |
Fuerst Technology Innovations Fuerst Technology Innovations |
9/2018 | Post-IPO Equity | $10.3M | 6/2022 | Post-IPO Debt | 1 | $50M |
OrbiMed OrbiMed |
1/2017 | Post-IPO Equity | 1 | $5.1M |
OurCrowd OurCrowd OurCrowd OurCrowd |
12/2015 | Post-IPO Equity | $400k | 6/2021 | Post-IPO Equity | $24M | 12/2019 | Private Placement | $21.3M | 12/2018 | Post-IPO Equity | $3M | 8/2011 | Seed Round | 1 | - |
Fuerst Technology Innovations Fuerst Technology Innovations |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 1/2022 | PhysiMax Technologies | |
| 5/2021 | wayForward | |
| 1/2021 | Upright Technologies |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
